Lung fluid clearance in chronic heart failure patients

Int J Cardiol. 2017 Oct 1:244:245-247. doi: 10.1016/j.ijcard.2017.05.096. Epub 2017 May 26.

Abstract

Chronic elevation of pulmonary microvascular pressure (Pmv) consistently leads to alveolocapillary barrier thickening and reduction in the filtration coefficient. In animal models of chronic heart failure (CHF) the lung remains dry despite hydrostatic forces. As fluid flux is bi-directional, it has been postulated that an increase in alveolar fluid clearance may facilitate the dry lung when Pmv is chronically elevated. In this study we aimed to examine alveolar fluid clearance in ambulatory patients with CHF secondary to left ventricular (LV) systolic dysfunction compared against non-CHF controls. Lung clearance following aerosol delivery of 99mtechnetium (Tc)-diethyl triaminepentaacetic acid (DTPA) was measured non-invasively by scintigraphy and half time of 99mTc-DTPA clearance (T (1/2)) was calculated by mono-exponential curve fit. Alveolar fluid clearance measured as half time DTPA clearance was significantly faster in CHF patients than controls (P=0.001). This was further defined by NYHA classification. No correlation was found between DTPA clearance and plasma epinephrine, norepinephrine or aldosterone hormone (P>0.05). Our results support an association between increasing alveolar fluid clearance and disease severity in CHF, and the concept of controlled bi-directional fluid flux in CHF associated with increasing Pmv, and represents another defence mechanism of the lung against pulmonary oedema.

Keywords: Aerosol scintigraphy; Catecholamines; Chronic heart failure; Pulmonary fluid clearance.

MeSH terms

  • Aged
  • Bronchoalveolar Lavage Fluid
  • Chronic Disease
  • Cohort Studies
  • Female
  • Heart Failure / diagnostic imaging*
  • Heart Failure / metabolism*
  • Humans
  • Lung / diagnostic imaging*
  • Lung / metabolism*
  • Male
  • Middle Aged
  • Organotechnetium Compounds / metabolism
  • Pentetic Acid / metabolism
  • Pulmonary Edema / diagnostic imaging*
  • Pulmonary Edema / metabolism*

Substances

  • Organotechnetium Compounds
  • Pentetic Acid